United States · Who invested in ADvantage Therapeutics?
ADvantage Therapeutics's investors include National Institute on Aging.
United States · Funded startup
Who invested in ADvantage Therapeutics
Funding summaryUpdated 26 Oct 2026
$2.5Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $2.5MSept 2025
- Investors
- 1
The rounds
- Sept 2025
Founders and team
From ADvantage Therapeutics's own website: 3 on the team.
- Jeffrey B. MaddenChief Executive Officer
- David BuchsbaumChief Financial Officer
- Olivier JarryChief Operating Officer
Quick answers about ADvantage Therapeutics
How much has ADvantage Therapeutics raised?
ADvantage Therapeutics has raised $2.5M across 1 round since 2025.
When did ADvantage Therapeutics last raise?
ADvantage Therapeutics's most recent round was a Grant of $2.5M in Sept 2025.
What was ADvantage Therapeutics's biggest round?
Its most recent round, $2.5M in Sept 2025, is also its largest on record.
Who backed ADvantage Therapeutics first?
ADvantage Therapeutics's first round on record, in Sept 2025, was backed by National Institute on Aging.
What stage is ADvantage Therapeutics at?
ADvantage Therapeutics's latest named round is a Grant, in Sept 2025.
Where is ADvantage Therapeutics based?
ADvantage Therapeutics is based in the United States.
Companies like ADvantage Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.